¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03
±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ¿Â-¿ÀÇÁ¶óÀÎ º´Çà  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 042-484-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:00~10:20 Current status of aHUS in Korea  ¾È¼­¿¬(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:20~10:45 Differential diagnosis of thrombotic microangiopathy  °í¿µÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:45~11:10 Optimal use of eculizumab in the treatment of aHUS in Korea  ±èÁø¼®(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 11:10~11:30 Panel discussion  ¹®¿µÃ¶ÀåÁØÈ£(ÀÌÈ­ÀǴ뼺±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 11:30~13:00 Lunch ¹× Oral presentation  ¹æ¼ö¹Ì À̽ÂÈñ ±è¼öÁ¾(¼­¿ïÀÇ´ë ±¹¸³º¸°Ç¿¬±¸¿ø ÃæºÏ´ë ÀÇÇаú) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:00~13:25 Update of Optimal Antithrombotic Therapy after TAVR  ¹ÎÇʱâ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:25~13:50 Cutting Edge on Optimal Therapy for Pulmonary Embolism  È²Çå±Ô(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:50~14:15 Present and Future of Aspirin as Primary Prevention of ASCVD  ³ª»óÈÆ(¼­¿ïÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 14:15~14:30 Panel discussion  Çã¾Ö¿µ½ÉµÎ¼±(°­¿øÀÇ´ëÀü³²ÀÇ´ë) 
È޽Ġ09-03  14:30~15:00 Coffee Break  () 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:00~15:25 Management of Antithrombotic Agents for Patients undergoing Procedure/Operation  À§Áø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:25~15:50 Cardiovascular Oncology: Optimal Antithrombotic Therapy in Cancer Patients  Á¶ÀÎÁ¤(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:50~16:15 Antithrombotic therapy for acute stage and secondary prevention of stroke  À̵¿È¯(À»ÁöÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 16:15~16:30 Panel discussion  ½Åµ¿È£°­¹Î°æ(¿¬¼¼ÀÇ´ëÇѸ²ÀÇ´ë) 
±âŸ 09-03  16:30~17:00 ¿ì¼ö¿¬Á¦»ó ¹ßÇ¥ ¹× ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦77Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2021) 3ÀÏÂ÷ : 2021-09-03
´ÙÀ½±Û Çѱ¹ÀÇÇб³À°ÇÐȸ (¿Â¶óÀÎ) 2021³âµµ ÇϹݱ⠽ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2021-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
360 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-09 1 1,063 2018-08-08
359 ¼­¿ï 2018³âµµ ³úÆÄÁ¤µµ°ü¸®À§¿øȸ Á¤±â±³À° : 2018-09-09 0 674 2018-08-08
358 °æ³² Á¦1ȸ µ¿ºÎ°æ³²Çмú´ëȸ : 2018-09-08 0 854 2018-08-08
357 ¼­¿ï °æÈñ´ëÇб³º´¿ø ¹é¹ÝÁõ°ú »ö¼ÒÁúȯ : 2018-09-08 0 848 2018-08-08
356 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08 0 382 2018-08-08
355 ¼­¿ï 2018³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 409 2018-08-08
354 ºÎ»ê 2018 ´ëÇѾȰúÀÇ»çȸ 5Â÷ ½ÉÆ÷Áö¿ò : 2018-09-08 0 725 2018-08-08
353 ºÎ»ê ´ëÇÑôÃß¿Ü°úÇÐȸ ºÎ¿ï°æ ´ë±¸ÇÕµ¿ ôÃßÁöȸ ¼¼¹Ì³ª : 2018-09-08 0 584 2018-08-08
352 ±¤ÁÖ ´ëÇÑôÃß¿Ü°úÇÐȸ 2018 ±¤ÁÖ±¹Á¦Ã´Ãß½ÉÆ÷Áö¿ò : 2018-09-08 0 339 2018-08-08
351 ÃæºÏ Á¦14Â÷ ´ëÀüÃæû¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 741 2018-08-08
350 ¼­¿ï 2018³â ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2018-09-07 0 743 2018-08-08
349 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 455 2018-08-08
348 ºÎ»ê ÁÁÀº°­¾Èº´¿ø Áø·á½Ç¿¡¼­ ÈçÈ÷ º¸´Â Áõ»óÀÇ Á¢±Ù°ú Ä¡·á : 2018-09-06 0 617 2018-08-08
347 ºÎ»ê ´ëÇѺñ´¢±â°úÇÐȸ ¼Ò¾Æºñ´¢ÀÇÇÐ ¹× ³²¼ºÀÇÇÐ : 2018-09-06 0 847 2018-08-08
346 ±¤ÁÖ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦281Â÷ Àü³²Áöȸ Áý´ãȸ : 2018-09-06 0 386 2018-08-08
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷